Glazer Capital LLC’s NRX Pharmaceuticals, Inc. Warrant NRXPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-66,710
| Closed | -$17K | – | 390 |
|
|
2020
Q3 | $17K | Hold |
66,710
| – | – | ﹤0.01% | 275 |
|
|
2020
Q2 | $30K | Hold |
66,710
| – | – | ﹤0.01% | 179 |
|
|
2020
Q1 | $4K | Hold |
66,710
| – | – | ﹤0.01% | 199 |
|
|
2019
Q4 | $10K | Hold |
66,710
| – | – | ﹤0.01% | 167 |
|
|
2019
Q3 | $11K | Hold |
66,710
| – | – | ﹤0.01% | 175 |
|
|
2019
Q2 | $15K | Buy |
66,710
+19,078
| +40% | +$4.29K | ﹤0.01% | 160 |
|
|
2019
Q1 | $9K | Sell |
47,632
-967
| -2% | -$183 | ﹤0.01% | 144 |
|
|
2018
Q4 | $19K | Sell |
48,599
-1
| -0% | – | ﹤0.01% | 141 |
|
|
2018
Q3 | $15K | Hold |
48,600
| – | – | ﹤0.01% | 135 |
|
|
2018
Q2 | $17K | Sell |
48,600
-17,044
| -26% | -$5.96K | ﹤0.01% | 127 |
|
|
2018
Q1 | $21K | Sell |
65,644
-23,800
| -27% | -$7.61K | ﹤0.01% | 109 |
|
|
2017
Q4 | $36K | Buy |
+89,444
| New | +$36K | 0.01% | 82 |
|